ClinicalTrials.gg
RecruitingNCT07297407Updated Oct 15, 2026

Prevention-in-PD-Study

An interventional study of Multidomain lifestyle intervention in Parkinson's Disease (PD), sponsored by University Hospital Schleswig-Holstein. Recruiting at 1 site in Germany. Open to participants aged 30 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by University Hospital Schleswig-Holstein · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.
Updated Oct 15, 2026Now RecruitingFirst site in Germany+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
99
Allocation
Not applicable
Ages
30 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 223 studies in Motor Activity with a site in Germany — 41 open to participants now, 48 under way, 1 of them phase 3. Motor Activity · Germany.

Planned enrollment
89th of 193
99 · median 86
Started
2026
with 11 others
No phase
140 of 223
34 open now
Primary completion
2027-09
later than 35 of 47 live
Registered
210th of 223
by date

Among the 223 studies in Motor Activity with a site in Germany, this one is the 89th largest by planned enrollment of the 193 interventional ones that give a count, is one of 12 that started in 2026, is one of 140 with no phase, reaches primary completion later than 35 of the 47 other live ones, and was the 210th registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

41 of the 223 studies in Motor Activity with a site in Germany are open now. Recruiting first, the newest first:

35 more — sign in →

All 41 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 30 Years to 85 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 223 studies in Motor Activity with a site in Germany, or all of them as a file.
02

Study summary

The goal of this clinical trial (feasibility study) is to learn if a multimodal lifestyle program can improve adherence to recommended lifestyle changes in people with REM Sleep Behavior Disroder (RBD) or Parkinson's disease (PD).

The main question it aims to answer is if individuals with RBD oder PD can follow a combined lifestyle program over six months Participants will take part in a six-month intervention program that includes: Physical training, Mediterranean diet counseling, Sleep counseling and cognitive training.

The program will be supported by psychoeducation, skills training, and personalization to make it practical and motivating.

Read the detailed description

Parkinson's disease (PD) is becoming more common worldwide, but there are still no treatments that can slow down or stop the disease. Lifestyle changes such as more physical activity, a healthy diet, good sleep, and mental training may help slow down the progression of the disease. However, it is often difficult for people to follow several lifestyle changes at the same time, and no study has yet tested how well this works in Parkinson's.

The PREVENTION-IN-PD study will test a new lifestyle program for people with PD and people with REM Sleep Behavior Disorder (RBD, at risk for developing Parkinson's Disease) in Germany. Over six months, participants will receive support in four areas: exercise, Mediterranean diet, sleep habits, and cognitive training. The program is designed to be practical, personalized, and motivating.

The main goal is to see whether people with PD and RBD can stick to these lifestyle changes over time. The study will also look at potential early effects on symptoms, quality of life, and overall health. If successful, this project will be the first step toward making lifestyle programs an important part of Parkinson's care in Germany and beyond.

03

Conditions studied

  • Parkinson's Disease (PD)

Browse trials for

Keywords

  • lifestyle
  • exercise
  • nutrition
  • cognitive training
  • sleep
04

Who can participate

Ages eligible
30 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All participants: ability to perform ; age 30-85
  • RBD group: polysomnographic proven diagnosis of isolated REM sleep behavior disorder (iRBD)
  • PD group: early to moderate disease (Hoehn \& Yahr stage 1-2.5), diagnosis according to the Movement Disorder Society diagnostic criteria for clinical Parkinson's Disease
  • Agreement to participate in group sessions and online meetings

Exclusion criteria

Exclusion Criteria:

  • dementia (Mini Mental Score, \< 19 points) (MMSE is specifically chosen here to avoid too frequent repetitions of the MoCA, which is used as an outcome parameter for the interventional trial)
  • physical inability to perform exercise training or other trainings as judged by a physician
  • manifest (severe) depression (Beck Depression Inventory, BDI-II > 29 points)
  • participation in other interventional trials
  • other significant diseases of the central nervous system
  • Planned change in medication within the following 6 months
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
99 participants (estimated)

Study arms

  • Experimental
    Multidomain lifestyle intervention

    Multidomain lifestyle intervention including physical and cognitive training, sleep and nutrition counceling

    Other: Multidomain lifestyle intervention

Interventions

  • OtherMultidomain lifestyle intervention

    Lifestyle intervention including physical and cognitive training, nutritional and sleep counseling

06

What researchers measure

Primary outcomes

  1. Adherence

    Adherence to the multimodal lifestyle intervention program is objectively recorded as the primary outcome parameter (participation in the planned training sessions in %). In addition, subjective adherence is recorded (assessment of the implementation of lifestyle measures in everyday life using a Likert scale).

    Time frame: From enrollement to the end of the intervention after 6 months.

07

Study locations

1 of 1 sites recruiting
  • University Hospital of Schleswig Holstein Campus Kiel
    Kiel, Germany
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Sep 2027, 17 months after the start.

Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 17 months is close to that.

Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

Completion moved once since we started tracking on Sep 25, 2026: Sep 2027 → Jan 2028, on Oct 15, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 16, 2025
First posted
Dec 22, 2025
StartActual
Apr 1, 2026
Primary completionEst.
Sep 2027
CompletionEst.
Jan 2028was Sep 2027
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 15, 2026
Sites
1 site added — first site in Germany
Show site
  • University Hospital of Schleswig Holstein Campus Kiel · Kiel, Germany
Oct 15, 2026
Study completion
Sep 2027→Jan 2028
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Germany
    Show site
    • University Hospital of Schleswig Holstein Campus Kiel · Kiel, Germany
    Study completion Sep 2027→Jan 2028
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07297407
Responsible party
Eva Schaeffer (PD Dr. Eva Schäffer, University Hospital Schleswig-Holstein) — Principal investigator
First posted
Dec 22, 2025
Start date
Apr 1, 2026
Primary completion
Sep 2027 (estimated)
Completion
Jan 2028 (estimated)
Last update
Oct 15, 2026

Study contacts

Eva Schaeffer
Contact
info.prevention.kiel@uksh.de
0049 043150023989

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion